Waiv: A new generation of AI-native precision diagnostics
We are pleased to announce OTB Ventures’ investment in Waiv’s $33 million Series A round, which we co-led alongside Alpha Intelligence Capital (AIC), with participation from Serena Data Ventures, Karista, and SistaFund. Waiv is Redefining Precision Oncology for the AI Era Waiv is a Paris-based company building the next generation of cancer diagnostics using artificial […]